Optiver Holding
PRME icon

Optiver Holding’s Prime Medicine PRME Stock Holding History

Optiver Holding’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$959 Sell
260
-632
-71% -$2.1K ﹤0.01% 2503
2026
Q1 		$3.1K Buy
892
+732
+458% +$2.79K ﹤0.01% 1647
2025
Q4 		$555 Sell
160
-738
-82% -$3.28K ﹤0.01% 2286
2025
Q3 		$4.97K Buy
+898
New +$3.65K ﹤0.01% 1744

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Optiver Holding's PRME Position: Q2 2026 in Review

Optiver Holding reduced its Prime Medicine (PRME) stake by 71% in Q2 2026, selling an estimated $2.1K and leaving 260 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #2503.

Optiver Holding first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.97K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Optiver Holding held 260 shares of Prime Medicine worth $959 as of Q2 2026.
  • Optiver Holding sold 632 Prime Medicine shares in Q2 2026, an estimated $2.1K.
  • Prime Medicine made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2503 holding.
  • Optiver Holding first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Prime Medicine position peaked at $4.97K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.